Strategies for discontinuation of proton pump inhibitors: a systematic review
Proton pump inhibitors (PPIs) are considered to be overprescribed. We conducted a systematic review of clinical studies on the discontinuation of PPIs. Discontinuations were reported across all studies ranging from 14% to 64% without deteriorating symptom control. Tapering seems to be a more effective discontinuation strategy than abrupt discontinuation.

Related Post